Molecular Diagnostics · Accuflex DX
Molecular HPV testing solutions for laboratories across Malaysia — from laboratory-based screening and genotyping workflows to molecular point-of-care options for outreach cervical cancer screening.
Human papillomavirus (HPV) DNA testing is a central component of modern cervical cancer screening programmes. Molecular HPV assays allow a laboratory to detect high-risk HPV infections and, where the workflow requires it, determine genotype-level information that supports clinical triage and reporting.
Accuflex DX provides molecular HPV testing solutions for government hospital laboratories, commercial laboratories and private hospital laboratories across Malaysia — together with the product consultation, workflow design and application support needed to implement them effectively.
Service-delivery workflow options for HPV molecular testing — illustrative environments supported by Accuflex DX workflows, not a clinical management algorithm.
Different laboratories approach HPV testing differently. The appropriate workflow depends on the setting, the volume of testing and the level of typing information each programme requires.
Qualitative high-risk HPV DNA testing for cervical cancer screening programmes, suited to high-volume screening workflows.
Genotyping assays provide type-level information, including specific identification of HPV types 16 and 18, where the screening programme calls for extended triage and reporting.
Sample-to-result automation supports laboratories processing high volumes of HPV tests with less manual handling and more consistent turnaround.
Compact, easy-to-operate molecular systems extend HPV testing beyond the central laboratory, supporting community and outreach cervical cancer screening initiatives.
No single approach is universally superior. Accuflex DX works with your team to match the workflow to your laboratory's setting, volume and reporting requirements.
High-risk HPV DNA diagnostic kit detecting 13 high-risk HPV genotypes, with specific identification of HPV types 16 and 18.
HPV genotyping assay covering 23 HPV genotypes, for laboratories and screening programmes requiring extended type-level information.
A molecular point-of-care HPV testing solution designed for simplified, rapid sample-to-result workflows, including outreach screening settings.
Testing requirements differ between laboratories and screening programmes. The most suitable HPV testing workflow is shaped by factors such as:
Accuflex DX's team helps laboratory managers and science officers weigh these factors against the available solutions before any procurement decision, and stays engaged through evaluation, installation, training and ongoing support.
From selecting the right technology to implementing it in your laboratory, Accuflex DX supports laboratories across Malaysia with product and application consultation, workflow design, evaluation, installation, training, method implementation, troubleshooting and ongoing technical and reagent support.
Molecular point-of-care and laboratory testing solutions for fast, accessible STI workflows.
Explore STI & Reproductive Health →The full Accuflex DX molecular diagnostics portfolio — applications, technologies and associated principals.
Explore Molecular Diagnostics →Explore practical educational resources related to HPV molecular testing, screening workflows and laboratory implementation.
Molecular Diagnostics
Understand what HPV DNA testing and liquid-based cytology detect, how their roles differ, and how they can fit within HPV-based cervical cancer screening pathways.
Read Article →HPV & Molecular Diagnostics
Understand HPV 16, HPV 18 and extended genotyping, including how genotype information can support risk stratification within appropriate clinical pathways.
Read Article →Have a question about our diagnostic solutions? We'd love to hear from you.
Enquire Now